Invention Grant
- Patent Title: IL2 and peptide-MHC complex fusion proteins and methods of use thereof
-
Application No.: US17127380Application Date: 2020-12-18
-
Publication No.: US12091440B2Publication Date: 2024-09-17
- Inventor: Jiaxi Wu , Tong Zhang , Maria del Pilar Molina-Portela , Eric Smith , Chia-Yang Lin , Thomas Craig Meagher
- Applicant: Regeneron Pharmaceuticals, Inc.
- Applicant Address: US NY Tarrytown
- Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee: Regeneron Pharmaceuticals, Inc.
- Current Assignee Address: US NY Tarrytown
- Agency: Biospark Intellectual Property Law
- Main IPC: C07K14/55
- IPC: C07K14/55 ; A61K35/17 ; A61K38/00 ; A61K38/20 ; A61K47/68 ; A61P35/00 ; C07K14/705 ; C07K14/715 ; C07K14/725 ; C07K14/74
Abstract:
The present disclosure relates to IL2 agonists with improved therapeutic profiles.
Public/Granted literature
- US20210187027A1 NOVEL IL2 AGONISTS AND METHODS OF USE THEREOF Public/Granted day:2021-06-24
Information query
